X
MIRM icon

Xponance’s Mirum Pharmaceuticals MIRM Stock Holding History

Xponance’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$622K Buy
5,315
+746
+16% +$74.9K ﹤0.01% 996
2026
Q1 		$422K Buy
4,569
+1,363
+43% +$128K ﹤0.01% 1079
2025
Q4 		$253K Buy
3,206
+55
+2% +$3.95K ﹤0.01% 1266
2025
Q3 		$231K Buy
+3,151
New +$200K ﹤0.01% 1286

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Xponance's MIRM Position: Q2 2026 in Review

Xponance increased its Mirum Pharmaceuticals (MIRM) stake by 16% in Q2 2026, buying an estimated $74.9K and bringing the position to 5,315 shares worth $622K. The position accounts for ﹤0.01% of the portfolio, ranked #996.

Xponance first reported a position in MIRM in Q3 2025 and has held it in 4 quarters since. 328 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Xponance held 5,315 shares of Mirum Pharmaceuticals worth $622K as of Q2 2026.
  • Xponance bought 746 Mirum Pharmaceuticals shares in Q2 2026, an estimated $74.9K.
  • Mirum Pharmaceuticals made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #996 holding.
  • Xponance first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 328 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.